Xifeng Dong

3PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 13, 2021
Pembrolizumab provides long-term survival benefits in advanced non-small cell lung cancer: The 5-year outcomes of the KEYNOTE-024 trial.

Fengtan Li, Xifeng Dong

|Sep 30, 2021
Primary mediastinal large B cell lymphoma.

Yating Yu, Xifeng Dong, Meifeng Tu

|Sep 27, 2021
Positive progress for non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: A novel targeted therapy option.

Weisan Zhang, Xifeng Dong

Pageof 1

Frequent Collaborators

1 joint publications

Yating Yu

1 joint publications

Huaquan Wang